SARS-CoV-2 Reduction

Authors
Varun Dwivedi, Jun-Gyu Park, Stephen Grenon, Nicholas Medendorp, Cory Hallam, Jordi B. Torrelles, Luis Martinez-Sobrido, Viraj Kulkarni
Facility
Texas Biomedical Research Institute; San Antonio, TX
Download
Full Report

Objective

To evaluate the efficacy and the dose response of NuvaWave Instant UV handheld device in reducing the SARS-CoV-2 virus on surfaces.

Methodology

SARS-CoV-2 was dried on a chambered glass slides and introduced in a NuvaWave robotic testing unit. The programed robotic unit facilitated the exposure of pre-determined UVC radiation dose to the virus for 1, 2, 4 and 8 seconds. Post-UVC exposure, virus was recovered and titered by plaque assay in Vero E6 cells. 

Summary of Results

The NuvaWave handheld device deactivated 99.88% of SARS-CoV-2 after one second of exposure.

Contact

USA Headquarters
3540 Toringdon Way, Suite 200 Charlotte, NC  28277
1 866 508 1118
info@wellairsolutions.com

Ireland Headquarters
DCU Innovation Campus
Old Finglas Road
Glasnevin, Dublin D11 KXN4
+353 1 907 2750
info@wellairsolutions.com

Contact WellAir

Social

Partners